fda warning letter compounding semaglutide october 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Semaglutide Patient Safety Updates |

Interactions Between Gut Bacteria and Bile in Health and Disease

After 2 1/2 weeks, I am down 4 1/2 pounds

Too many physicians dismiss low testosterone as a normal part of aging rather than recognizing it as a treatable condition with profound metabolic implications

Common Concentrations Used in Published Research The concentrations used in published preclinical and analytical retatrutide research vary by application chromatographic characterization, receptor binding assays, and pharmacokinetic studies each call for different working concentrations

Abstract Primordial follicles form the non-renewable germline reserve in female mammals